SHL Telemedicine (LTS:0QMX) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QMX SHL Telemedicine Ltd LTS:0QMX
45 GF Score
Price CHF1.05
GF Value CHF2.62
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SHL Telemedicine Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0QMX vs VEEV, BTSG, TEM: Short Interest Comparison

For the Health Information Services subindustry, SHL Telemedicine's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SHL Telemedicine Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SHL Telemedicine's Short Interest distribution charts can be found below:

* The bar in red indicates where SHL Telemedicine's Short Interest falls into.


LTS:0QMX
45GF Score
SHL Telemedicine Ltd LTS:0QMX
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SHL Telemedicine (LTS:0QMX) Overvalued in 2026?

Based on GuruFocus' analysis, SHL Telemedicine stock appears to be undervalued. The current stock price of CHF1.05 is trading 59.9% below its estimated GF Value™ of CHF2.62. GuruFocus considers SHL Telemedicine to be Possible Value Trap.

Key valuation signals for LTS:0QMX:

  • Short Interest:
  • GF Value™: CHF2.62 vs. price of CHF1.05 (59.9% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QMX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SHL Telemedicine Business Description

Other Exchanges SHLTN:Switzerland
Address 90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. The company consists of the transmission of medical data by an individual, from a remote location to a medical call center, through telecommunication networks. The company provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments are Israel, Europe, and the rest of the world, out of which majority of revenue comes from Israel.
45GF Score

Get the complete analysis for LTS:0QMX

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF1.05
Price
CHF2.62
GF Value